Literature DB >> 3011052

Further experience with Kaposi's sarcoma in Uganda.

D Serwadda, W Carswell, W O Ayuko, W Wamukota, P Madda, R G Downing.   

Abstract

Four Ugandan patients (1 women, 3 men) with generalized Kaposi's sarcoma (KS) were seen in the Uganda Cancer Institute between October 1983 and December 1984. They presented with generalized lymphadenopathy, plaques/nodules on the body, general swelling of the head, oral and visceral involvement and respiratory distress. Initial responses to adriamycin as a single or a combination chemotherapy of actinomycin D, vincristine, adriamycin and imidazole carboxamide appeared to be favourable but no sustained response was obtained. Serological tests for human T-lymphotropic virus (HTLV-II) antibodies were positive in all 4 cases.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3011052      PMCID： PMC2001431          DOI： 10.1038/bjc.1986.78

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   7.640


  14 in total

1.  Treatment of Kaposi's sarcoma by combination of actinomycin-D, vincristine and imidazole carboxamide (nsc-45388): results of a randomized clinical trial.

Authors:  C L Olweny; T Toya; E K Mbidde; S K Lwanga
Journal:  Int J Cancer       Date:  1974-11-15       Impact factor: 7.396

2.  Effective treatment of Kaposi's sarcoma with 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388).

Authors:  C L Vogel; A Primack; R Owor; S K Kyalwazi
Journal:  Cancer Chemother Rep       Date:  1973-02

3.  Studies in Kaposi's sarcoma. Postmortem findings and disease patterns in women.

Authors:  A C Templeton
Journal:  Cancer       Date:  1972-09       Impact factor: 6.860

4.  Kaposi's sarcoma in Uganda: a clinico-pathological study.

Authors:  J F Taylor; A C Templeton; C L Vogel; J L Ziegler; S K Kyalwazi
Journal:  Int J Cancer       Date:  1971-07-15       Impact factor: 7.396

5.  Slim disease: a new disease in Uganda and its association with HTLV-III infection.

Authors:  D Serwadda; R D Mugerwa; N K Sewankambo; A Lwegaba; J W Carswell; G B Kirya; A C Bayley; R G Downing; R S Tedder; S A Clayden; R A Weiss; A G Dalgleish
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

6.  Management of Kaposi's sarcoma. Chemotherapy II.

Authors:  C L Olweny
Journal:  Antibiot Chemother (1971)       Date:  1981

7.  Kaposi's sarcoma presenting with diarrhea and protein-losing enteropathy.

Authors:  B H Novis; H King; S Bank
Journal:  Gastroenterology       Date:  1974-11       Impact factor: 22.682

8.  Aggressive Kaposi's sarcoma in Zambia, 1983.

Authors:  A C Bayley
Journal:  Lancet       Date:  1984-06-16       Impact factor: 79.321

9.  Acquired immunodeficiency syndrome is an opportunistic infection and Kaposi's sarcoma results from secondary immune stimulation.

Authors:  J A Levy; J L Ziegler
Journal:  Lancet       Date:  1983-07-09       Impact factor: 79.321

10.  Childhood Kaposi's sarcoma: clinical features and therapy.

Authors:  C L Olweny; A Kaddumukasa; I Atine; R Owor; I Magrath; J L Ziegler
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640
View more
  3 in total

1.  Seroprevalence of Human herpesvirus 8 (HHV-8) and incidence of Kaposi's sarcoma in Iran.

Authors:  Somayeh Jalilvand; Zabihollah Shoja; Talat Mokhtari-Azad; Rakhshandeh Nategh; Ahmad Gharehbaghian
Journal:  Infect Agent Cancer       Date:  2011-04-28       Impact factor: 2.965

2.  African Kaposi's sarcoma in the light of global AIDS: antiblackness and viral visibility.

Authors:  Pawan Singh; Lisa Cartwright; Cristina Visperas
Journal:  J Bioeth Inq       Date:  2014-10-11       Impact factor: 2.216

3.  Pervasive and non-random recombination in near full-length HIV genomes from Uganda.

Authors:  Heather E Grant; Emma B Hodcroft; Deogratius Ssemwanga; John M Kitayimbwa; Gonzalo Yebra; Luis Roger Esquivel Gomez; Dan Frampton; Astrid Gall; Paul Kellam; Tulio de Oliveira; Nicholas Bbosa; Rebecca N Nsubuga; Freddie Kibengo; Tsz Ho Kwan; Samantha Lycett; Rowland Kao; David L Robertson; Oliver Ratmann; Christophe Fraser; Deenan Pillay; Pontiano Kaleebu; Andrew J Leigh Brown
Journal:  Virus Evol       Date:  2020-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.